These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 26135687)

  • 41. D2-resected stage IIIc gastric cancer patients benefit from adjuvant chemoradiotherapy.
    Peng J; Wei Y; Zhou F; Dai J; Zhong Y; Xie C; Qin Y; Gong J; Xiong B; Zhou Y
    Cancer Med; 2016 Oct; 5(10):2773-2780. PubMed ID: 27666138
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is there a role for surgery with adequate nodal evaluation alone in gastric adenocarcinoma?
    Dudeja V; Habermann EB; Abraham A; Zhong W; Parsons HM; Tseng JF; Al-Refaie WB
    J Gastrointest Surg; 2012 Feb; 16(2):238-46; discussion 246-7. PubMed ID: 22089951
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemoradiation Improves Survival Compared With Chemotherapy Alone in Unresected Nonmetastatic Gastric Cancer.
    Li R; Hou WH; Chao J; Woo Y; Glaser S; Amini A; Nelson RA; Chen YJ
    J Natl Compr Canc Netw; 2018 Aug; 16(8):950-958. PubMed ID: 30099371
    [No Abstract]   [Full Text] [Related]  

  • 44. Evaluation of N-ratio in selecting patients for adjuvant chemoradiotherapy after d2-gastrectomy.
    Costa Junior WL; Coimbra FJ; Batista TP; Ribeiro HS; Diniz AL
    Arq Gastroenterol; 2013; 50(4):257-63. PubMed ID: 24474226
    [TBL] [Abstract][Full Text] [Related]  

  • 45. What is the role of nodal ratio as a prognostic factor for gastric cancer nowadays? Comparison with new TNM staging system and analysis according to the number of resected nodes.
    Aurello P; Catracchia V; Petrucciani N; D'Angelo F; Leonardo G; Picchetto A; Antolino L; Magistri P; Terrenato I; Lauro A; Ramacciato G
    Am Surg; 2013 May; 79(5):483-91. PubMed ID: 23635583
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic factors associated with survival in a large cohort of gastric cancer patients resected over a decade at a single Italian center: the Cremona experience.
    Ghidini M; Donida BM; Totaro L; Ratti M; Pizzo C; Benzoni I; Lomiento D; Aldighieri F; Toppo L; Ranieri V; Senti C; Tanzi G; Martinotti M; Passalacqua R; Rovatti M; Tomasello G
    Clin Transl Oncol; 2020 Jul; 22(7):1004-1012. PubMed ID: 31599376
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma: Data From the National Cancer Data Base.
    Amini A; Waxweiler TV; Brower JV; Jones BL; McDermott JD; Raben D; Ghosh D; Bowles DW; Karam SD
    JAMA Otolaryngol Head Neck Surg; 2016 Nov; 142(11):1100-1110. PubMed ID: 27541166
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of laparoscopic spleen-preserving splenic hilar lymphadenectomy on the surgical outcome of proximal gastric cancer: a propensity score-matched, case-control study.
    Huang CM; Chen T; Lin JX; Chen QY; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Cao LL; Lin M; Tu RH
    Surg Endosc; 2017 Mar; 31(3):1383-1392. PubMed ID: 27450211
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Implication of lymph node staging in migration and different treatment strategies for stage T2N0M0 and T1N1M0 resected gastric cancer: a SEER population analysis.
    Wang Y; Zhang J; Guo S; Dong Z; Meng X; Zheng G; Yang D; Zheng Z; Zhao Y
    Clin Transl Oncol; 2019 Nov; 21(11):1499-1509. PubMed ID: 30903518
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Impact of clinicopathological features and extent of lymph node dissection on the prognosis in early gastric cancer patients].
    Wu H; Wang L; He YL; Xu JB; Cai SR; Ma JP; Chen CQ; Zhang XH; Zhan WH
    Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):509-13. PubMed ID: 24257302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage.
    Shin K; Park SJ; Lee J; Park CH; Song KY; Lee HH; Seo HS; Jung YJ; Park JM; Lee SH; Roh SY; Kim IH
    BMC Cancer; 2019 Dec; 19(1):1232. PubMed ID: 31852475
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of age on nodal metastases and survival in gastric cancer.
    Ahmad A; Khan H; Cholankeril G; Katz SC; Somasundar P
    J Surg Res; 2016 May; 202(2):428-35. PubMed ID: 27229119
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical implication of an insufficient number of examined lymph nodes after curative resection for gastric cancer.
    Son T; Hyung WJ; Lee JH; Kim YM; Kim HI; An JY; Cheong JH; Noh SH
    Cancer; 2012 Oct; 118(19):4687-93. PubMed ID: 22415925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database.
    Smith DD; Schwarz RR; Schwarz RE
    J Clin Oncol; 2005 Oct; 23(28):7114-24. PubMed ID: 16192595
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
    Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
    Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for esophagogastric adenocarcinoma.
    Zahoor H; Luketich JD; Levy RM; Awais O; Winger DG; Gibson MK; Nason KS
    J Thorac Cardiovasc Surg; 2015 Feb; 149(2):538-47. PubMed ID: 25454907
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognosis for gastric carcinomas with an insufficient number of examined negative lymph nodes.
    Martinez-Ramos D; Calero A; Escrig-Sos J; Mingol F; Daroca-Jose JM; Sauri M; Arroyo A; Salvador-Sanchis JL; de Juan M; Calpena R; Lacueva FJ
    Eur J Surg Oncol; 2014 Mar; 40(3):358-65. PubMed ID: 24075824
    [TBL] [Abstract][Full Text] [Related]  

  • 58. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.
    Díez M; Medrano MJ; Gutierrez A; López A; Mugüerza JM; Hernández P; Lozano O; Noguerales F; Ruíz A; Granell J
    Anticancer Res; 2000; 20(5C):3929-33. PubMed ID: 11268479
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact on survival of the number of lymph nodes removed in patients with node-negative gastric cancer submitted to extended lymph node dissection.
    Biffi R; Botteri E; Cenciarelli S; Luca F; Pozzi S; Valvo M; Sonzogni A; Chiappa A; Leal Ghezzi T; Rotmensz N; Bagnardi V; Andreoni B
    Eur J Surg Oncol; 2011 Apr; 37(4):305-11. PubMed ID: 21288685
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
    Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
    Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.